ME03776B - Derivati piridin-2(1h)-on hinolinona kao inhibitori mutirane izocitrat dehidrogenaze - Google Patents

Derivati piridin-2(1h)-on hinolinona kao inhibitori mutirane izocitrat dehidrogenaze

Info

Publication number: ME03776B
Authority: ME; Montenegro
Prior art keywords: pyridin; isocitrate dehydrogenase; dehydrogenase inhibitors; quinolinone derivatives; quinolinone
Prior art date: 2014-09-19

Application number

MEP-2020-78A

Other languages

German (de)

English (en)

French (fr)

Inventor

Susan Ashwell

Ann-Marie Campbell

Justin Andrew Caravella

R Bruce Diebold

Anna Ericsson

Gary Gustafson

Jian Lin

Wei Lu

Zhongguo Wang

David R Lancia Jr

Original Assignee

Forma Therapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-09-19

Filing date

2015-09-18

Publication date

2021-04-20

2015-09-18 Application filed by Forma Therapeutics Inc filed Critical Forma Therapeutics Inc

2021-04-20 Publication of ME03776B publication Critical patent/ME03776B/me

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

MEP-2020-78A 2014-09-19 2015-09-18 Derivati piridin-2(1h)-on hinolinona kao inhibitori mutirane izocitrat dehidrogenaze ME03776B (me)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201462053006P	2014-09-19	2014-09-19
US201562128089P	2015-03-04	2015-03-04
US201562150812P	2015-04-21	2015-04-21
EP18198969.0A EP3447050B1 (en)	2014-09-19	2015-09-18	Pyridin-2(1h)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Publications (1)

Publication Number	Publication Date
ME03776B true ME03776B (me)	2021-04-20

Family

ID=54291606

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-2020-78A ME03776B (me)	2014-09-19	2015-09-18	Derivati piridin-2(1h)-on hinolinona kao inhibitori mutirane izocitrat dehidrogenaze

Country Status (37)

Country	Link
US (8)	US9834539B2 (me)
EP (4)	EP4257131A3 (me)
JP (1)	JP6648115B2 (me)
KR (1)	KR102209667B1 (me)
CN (3)	CN107001328B (me)
AU (3)	AU2015317329B2 (me)
BR (1)	BR112017005238B1 (me)
CA (1)	CA2961817C (me)
CL (1)	CL2017000658A1 (me)
CO (1)	CO2017003241A2 (me)
CY (2)	CY1121149T1 (me)
DK (2)	DK3194376T3 (me)
EA (1)	EA034336B1 (me)
EC (1)	ECSP17022933A (me)
ES (3)	ES2953347T3 (me)
FI (1)	FI3733662T3 (me)
HR (1)	HRP20200666T1 (me)
HU (2)	HUE041460T2 (me)
IL (3)	IL292608B2 (me)
LT (2)	LT3194376T (me)
MA (2)	MA53352A (me)
ME (1)	ME03776B (me)
MX (2)	MX2017003404A (me)
MY (2)	MY197533A (me)
NZ (1)	NZ730373A (me)
PE (1)	PE20171056A1 (me)
PH (1)	PH12017500517B1 (me)
PL (3)	PL3447050T3 (me)
PT (3)	PT3194376T (me)
RS (2)	RS58184B1 (me)
SA (1)	SA517381129B1 (me)
SG (1)	SG11201702194SA (me)
SI (2)	SI3447050T1 (me)
SM (2)	SMT202000212T1 (me)
TW (1)	TWI686390B (me)
WO (1)	WO2016044789A1 (me)
ZA (3)	ZA201702127B (me)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN108524505A (zh)	2009-03-13	2018-09-14	安吉奥斯医药品有限公司	用于细胞增殖相关病症的方法和组合物
CA2793835C (en) *	2009-10-21	2021-07-20	Agios Pharmaceuticals, Inc.	Methods and compositions for cell-proliferation-related disorders
UA122121C2 (uk)	2014-02-06	2020-09-25	Хептерс Терап'Ютікс Лімітед	Біциклічні азотовмісні сполуки як агоністи мускаринового м1 рецептора i/або м4 рецептора
CA2961793C (en)	2014-09-19	2021-03-16	Forma Therapeutics, Inc.	Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
ES2706525T3 (es)	2014-09-19	2019-03-29	Forma Therapeutics Inc	Derivados de piridinilquinolinona como inhibidores de isocitrato deshidrogenasa mutante
EP3194375B1 (en)	2014-09-19	2018-11-21	Forma Therapeutics, Inc.	Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
PT3194376T (pt) *	2014-09-19	2019-02-04	Forma Therapeutics Inc	Derivados da piridin-2(1h)-ona-quinolinona como inibidores da isocitrato-desidrogenase mutante
TN2017000092A1 (en)	2014-09-19	2018-07-04	Bayer Pharma AG	Benzyl substituted indazoles as bub1 inhibitors.
CA2971872C (en) *	2014-12-22	2023-10-10	The United States Of America As Represented By The Secretary, Department Of Health And Human Services	Mutant idh1 inhibitors useful for treating cancer
US10294206B2 (en)	2015-04-21	2019-05-21	Forma Tm2, Inc.	Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
US10407419B2 (en)	2015-04-21	2019-09-10	Forma Therapeutics, Inc.	Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
CN110869349B (zh)	2017-05-04	2025-07-22	发现号收购集团	作为例如用于保护植物的害虫防治剂的2-{[2-(苯氧基甲基)吡啶-5-基]氧基}乙胺衍生物及相关化合物
US11013734B2 (en)	2018-05-16	2021-05-25	Forma Therapeutics, Inc.	Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation
US11013733B2 (en) *	2018-05-16	2021-05-25	Forma Therapeutics, Inc.	Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1)
WO2020232381A1 (en)	2019-05-16	2020-11-19	Forma Therapeutics, Inc.	INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)
US11311527B2 (en)	2018-05-16	2022-04-26	Forma Therapeutics, Inc.	Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)
WO2019222553A1 (en) *	2018-05-16	2019-11-21	Forma Therapeutics, Inc.	Inhibiting mutant idh-1
EP4215197A1 (en)	2018-05-16	2023-07-26	Forma Therapeutics, Inc.	Inhibiting mutant idh-1
WO2019222551A1 (en)	2018-05-16	2019-11-21	Forma Therapeutics, Inc.	Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
TW202104207A (zh) *	2019-04-17	2021-02-01	美商健生生物科技公司	二氫乳清酸脫氫酶抑制劑
US11566013B1 (en) *	2019-11-20	2023-01-31	Forma Therapeutics, Inc.	Inhibiting mutant isocitrate dehydrogenase 1 (mIDH1)
CN112341389B (zh) *	2020-10-27	2022-07-29	浙江工业大学	一种含氮芳杂环取代的喹啉甲酰胺类衍生物及其应用
CN112321571B (zh) *	2020-10-27	2022-06-03	浙江工业大学	2-呋喃-喹啉-4-甲酰胺类化合物及其应用
CN115850240B (zh) *	2022-12-28	2023-09-19	北京康立生医药技术开发有限公司	一种治疗急性髓系白血病药物奥卢他西尼的合成方法

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL99731A0 (en)	1990-10-18	1992-08-18	Merck & Co Inc	Hydroxylated pyridine derivatives,their preparation and pharmaceutical compositions containing them
US5262564A (en)	1992-10-30	1993-11-16	Octamer, Inc.	Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
US20030105124A1 (en)	2000-04-27	2003-06-05	Susan Beth Sobolov-Jaynes	Substituted benzolactam compounds
AU2003243497A1 (en)	2002-06-12	2003-12-31	Millennium Pharmaceuticals, Inc.	Antagonists of melanin concentrating hormone receptor
AU2003284399A1 (en)	2002-11-14	2004-06-03	Kyowa Hakko Kogyo Co., Ltd.	Plk inhibitors
RU2284325C2 (ru)	2003-12-17	2006-09-27	Общество С Ограниченной Ответственностью "Асинэкс Медхим"	Производные фенил-3-аминометил-хинолона-2 в качестве ингибиторов no-синтетазы, способ их получения, биологически активные соединения и фармацевтическая композиция на их основе
JPWO2005095382A1 (ja)	2004-03-30	2007-08-16	協和醗酵工業株式会社	抗腫瘍剤
WO2006054912A1 (fr)	2004-11-18	2006-05-26	Obchestvo S Ogranichennoy Otvetstvennost'u 'asineks Medhim'	Derives d'aryl(hetaryl)-3-aminomethylchinolone-2 utilises en tant qu'inhibiteurs de no-synthetase et de cyclo-oxygenase-2, procedes de leur fabrication et compositions pharmaceutiques sur leur base
TW200803855A (en)	2006-02-24	2008-01-16	Kalypsys Inc	Quinolones useful as inducible nitric oxide synthase inhibitors
CA2657287A1 (en) *	2006-07-17	2008-01-24	Merck & Co., Inc.	1-hydroxy naphthyridine compounds as anti-hiv agents
JP2010043004A (ja)	2006-12-06	2010-02-25	Dainippon Sumitomo Pharma Co Ltd	新規２環性複素環化合物
CA2684968C (en)	2007-04-30	2015-07-07	Prometic Biosciences Inc.	Compounds, compositions containing such compounds, and methods of treatment of cancer and autoimmune diseases using such compounds
AU2010259002B2 (en)	2009-06-08	2014-03-20	Nantbio, Inc.	Triazine derivatives and their therapeutical applications
ES2642109T3 (es) *	2009-12-09	2017-11-15	Agios Pharmaceuticals, Inc.	Compuestos terapéuticamente activos para su uso en el tratamiento de cáncer caracterizados por tener una mutación de IDH
WO2012006104A2 (en)	2010-06-28	2012-01-12	Academia Sinica, Taiwan	Compounds and methods for treating tuberculosis infection
CN102558049B (zh) *	2010-12-17	2015-02-04	中国科学院上海药物研究所	一类双香豆素类化合物及其制备方法和用途
US20120184548A1 (en)	2011-01-19	2012-07-19	Romyr Dominique	Carboxylic acid aryl amides
US20120184562A1 (en)	2011-01-19	2012-07-19	Kin-Chun Luk	1,6- and 1,8-naphthyridines
WO2012129562A2 (en)	2011-03-24	2012-09-27	The Scripps Research Institute	Compounds and methods for inducing chondrogenesis
CN102827170A (zh)	2011-06-17	2012-12-19	安吉奥斯医药品有限公司	治疗活性组合物和它们的使用方法
CN103814020B (zh) *	2011-06-17	2017-07-14	安吉奥斯医药品有限公司	治疗活性组合物和它们的使用方法
WO2013046136A1 (en)	2011-09-27	2013-04-04	Novartis Ag	3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
EP2793881B1 (en)	2011-12-21	2018-10-31	The Regents of the University of Colorado	Anti-cancer compounds targeting ral gtpase
DK2800743T3 (en)	2012-01-06	2018-06-14	Agios Pharmaceuticals Inc	THERAPEUTIC ACTIVE RELATIONS AND PROCEDURES FOR USE THEREOF
WO2014141153A1 (en)	2013-03-14	2014-09-18	Novartis Ag	3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
WO2015003146A1 (en)	2013-07-03	2015-01-08	Georgetown University	Boronic acid derivatives of resveratrol for activating deacetylase enzymes
EP3105209B1 (en)	2014-02-11	2019-08-21	Bayer Pharma Aktiengesellschaft	Benzimidazol-2-amines as midh1 inhibitors
PT3194376T (pt)	2014-09-19	2019-02-04	Forma Therapeutics Inc	Derivados da piridin-2(1h)-ona-quinolinona como inibidores da isocitrato-desidrogenase mutante
EP3194375B1 (en)	2014-09-19	2018-11-21	Forma Therapeutics, Inc.	Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
CA2961793C (en)	2014-09-19	2021-03-16	Forma Therapeutics, Inc.	Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
ES2706525T3 (es)	2014-09-19	2019-03-29	Forma Therapeutics Inc	Derivados de piridinilquinolinona como inhibidores de isocitrato deshidrogenasa mutante
CA2971872C (en)	2014-12-22	2023-10-10	The United States Of America As Represented By The Secretary, Department Of Health And Human Services	Mutant idh1 inhibitors useful for treating cancer
GB2533925A (en)	2014-12-31	2016-07-13	Univ Bath	Antimicrobial compounds, compositions and methods
US10407419B2 (en)	2015-04-21	2019-09-10	Forma Therapeutics, Inc.	Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
US10294206B2 (en)	2015-04-21	2019-05-21	Forma Tm2, Inc.	Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
US10253041B2 (en)	2015-07-27	2019-04-09	Eli Lilly And Company	7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds and their use as mutant IDH1 inhibitors
WO2017146794A1 (en)	2016-02-26	2017-08-31	Celgene Corporation	Idh2 inhibitors for the treatment of haematological maligancies and solid tumours
JP6682043B2 (ja)	2016-06-06	2020-04-15	イーライリリーアンドカンパニー	変異体ｉｄｈ１阻害剤
US10836759B2 (en)	2016-06-22	2020-11-17	The University Of North Carolina At Chapel Hill	Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer
EA036112B1 (ru)	2016-12-16	2020-09-29	Эли Лилли Энд Компани	7-фенилэтиламино-4h-пиримидо[4,5-d][1,3]оксазин-2-оновые соединения в качестве ингибиторов мутантных idh1 и idh2

2015
- 2015-09-18 PT PT15778433T patent/PT3194376T/pt unknown
- 2015-09-18 ES ES20157755T patent/ES2953347T3/es active Active
- 2015-09-18 HU HUE15778433A patent/HUE041460T2/hu unknown
- 2015-09-18 AU AU2015317329A patent/AU2015317329B2/en active Active
- 2015-09-18 CA CA2961817A patent/CA2961817C/en active Active
- 2015-09-18 SM SM20200212T patent/SMT202000212T1/it unknown
- 2015-09-18 LT LTEP15778433.1T patent/LT3194376T/lt unknown
- 2015-09-18 CN CN201580050441.5A patent/CN107001328B/zh active Active
- 2015-09-18 EP EP23176702.1A patent/EP4257131A3/en active Pending
- 2015-09-18 CN CN202311265288.0A patent/CN117695280A/zh active Pending
- 2015-09-18 DK DK15778433.1T patent/DK3194376T3/en active
- 2015-09-18 US US14/858,167 patent/US9834539B2/en active Active
- 2015-09-18 MY MYPI2020001463A patent/MY197533A/en unknown
- 2015-09-18 JP JP2017515059A patent/JP6648115B2/ja active Active
- 2015-09-18 SG SG11201702194SA patent/SG11201702194SA/en unknown
- 2015-09-18 PE PE2017000471A patent/PE20171056A1/es unknown
- 2015-09-18 BR BR112017005238-5A patent/BR112017005238B1/pt active IP Right Grant
- 2015-09-18 MA MA053352A patent/MA53352A/fr unknown
- 2015-09-18 MX MX2017003404A patent/MX2017003404A/es active IP Right Grant
- 2015-09-18 PT PT181989690T patent/PT3447050T/pt unknown
- 2015-09-18 LT LTEP18198969.0T patent/LT3447050T/lt unknown
- 2015-09-18 TW TW104131044A patent/TWI686390B/zh active
- 2015-09-18 MY MYPI2017700895A patent/MY176250A/en unknown
- 2015-09-18 PT PT201577558T patent/PT3733662T/pt unknown
- 2015-09-18 FI FIEP20157755.8T patent/FI3733662T3/fi active
- 2015-09-18 EA EA201790657A patent/EA034336B1/ru unknown
- 2015-09-18 RS RS20181586A patent/RS58184B1/sr unknown
- 2015-09-18 ES ES15778433T patent/ES2704897T3/es active Active
- 2015-09-18 NZ NZ73037315A patent/NZ730373A/en unknown
- 2015-09-18 ES ES18198969T patent/ES2790640T3/es active Active
- 2015-09-18 PH PH1/2017/500517A patent/PH12017500517B1/en unknown
- 2015-09-18 EP EP18198969.0A patent/EP3447050B1/en active Active
- 2015-09-18 PL PL18198969T patent/PL3447050T3/pl unknown
- 2015-09-18 MX MX2019013203A patent/MX385512B/es unknown
- 2015-09-18 SM SM20190018T patent/SMT201900018T1/it unknown
- 2015-09-18 ME MEP-2020-78A patent/ME03776B/me unknown
- 2015-09-18 IL IL292608A patent/IL292608B2/en unknown
- 2015-09-18 MA MA040481A patent/MA40481A/fr unknown
- 2015-09-18 PL PL15778433T patent/PL3194376T3/pl unknown
- 2015-09-18 EP EP20157755.8A patent/EP3733662B1/en active Active
- 2015-09-18 HU HUE20157755A patent/HUE062424T2/hu unknown
- 2015-09-18 SI SI201531117T patent/SI3447050T1/sl unknown
- 2015-09-18 SI SI201530537T patent/SI3194376T1/sl unknown
- 2015-09-18 PL PL20157755.8T patent/PL3733662T3/pl unknown
- 2015-09-18 RS RS20200418A patent/RS60140B1/sr unknown
- 2015-09-18 EP EP15778433.1A patent/EP3194376B1/en active Active
- 2015-09-18 DK DK18198969.0T patent/DK3447050T3/da active
- 2015-09-18 KR KR1020177010585A patent/KR102209667B1/ko active Active
- 2015-09-18 CN CN202010391529.6A patent/CN111909130B/zh active Active
- 2015-09-18 WO PCT/US2015/051055 patent/WO2016044789A1/en not_active Ceased
2017
- 2017-03-07 US US15/452,256 patent/US20170174658A1/en not_active Abandoned
- 2017-03-14 IL IL251163A patent/IL251163B/en active IP Right Grant
- 2017-03-17 CL CL2017000658A patent/CL2017000658A1/es unknown
- 2017-03-19 SA SA517381129A patent/SA517381129B1/ar unknown
- 2017-03-27 ZA ZA2017/02127A patent/ZA201702127B/en unknown
- 2017-04-03 CO CONC2017/0003241A patent/CO2017003241A2/es unknown
- 2017-04-13 EC ECIEPI201722933A patent/ECSP17022933A/es unknown
2018
- 2018-04-27 US US15/964,844 patent/US10414752B2/en active Active
2019
- 2019-01-21 CY CY20191100075T patent/CY1121149T1/el unknown
- 2019-03-01 US US16/290,240 patent/US10550098B2/en active Active
- 2019-04-17 ZA ZA2019/02446A patent/ZA201902446B/en unknown
- 2019-12-12 US US16/712,951 patent/US10889567B2/en active Active
- 2019-12-16 AU AU2019283765A patent/AU2019283765B2/en active Active
2020
- 2020-04-24 HR HRP20200666TT patent/HRP20200666T1/hr unknown
- 2020-05-04 CY CY20201100407T patent/CY1122865T1/el unknown
- 2020-11-23 US US17/101,018 patent/US11498913B2/en active Active
2021
- 2021-04-18 IL IL282363A patent/IL282363B/en unknown
- 2021-08-10 AU AU2021215141A patent/AU2021215141B2/en active Active
2022
- 2022-11-09 US US17/984,069 patent/US20230125739A1/en not_active Abandoned
2023
- 2023-04-14 ZA ZA2023/04409A patent/ZA202304409B/en unknown
- 2023-11-09 US US18/506,060 patent/US12275715B2/en active Active

Also Published As

Publication number	Publication date
ZA201902446B (en)	2023-12-20
IL292608A (en)	2022-07-01
EP4257131A2 (en)	2023-10-11
EA034336B1 (ru)	2020-01-29
CN117695280A (zh)	2024-03-15
CY1121149T1 (el)	2020-05-29
MX385512B (es)	2025-03-18
US12275715B2 (en)	2025-04-15
HUE062424T2 (hu)	2023-11-28
HUE041460T2 (hu)	2019-05-28
IL251163B (en)	2021-05-31
EA201790657A8 (ru)	2018-02-28
MX2017003404A (es)	2017-07-28
CN107001328A (zh)	2017-08-01
PL3733662T3 (pl)	2024-01-22
MA40481A (fr)	2017-07-26
AU2015317329B2 (en)	2019-10-31
US20200223822A1 (en)	2020-07-16
US20230125739A1 (en)	2023-04-27
SI3447050T1 (sl)	2020-08-31
MX2019013203A (es)	2020-01-20
DK3447050T3 (da)	2020-03-09
EP3194376A1 (en)	2017-07-26
PT3194376T (pt)	2019-02-04
US20210078973A1 (en)	2021-03-18
US20160083366A1 (en)	2016-03-24
PL3447050T3 (pl)	2020-07-27
JP2017528487A (ja)	2017-09-28
ES2704897T3 (es)	2019-03-20
EP3447050A1 (en)	2019-02-27
PE20171056A1 (es)	2017-07-21
EP3733662B1 (en)	2023-06-07
US10550098B2 (en)	2020-02-04
PT3733662T (pt)	2023-08-18
AU2019283765A1 (en)	2020-01-16
MA53352A (fr)	2021-09-15
SMT202000212T1 (it)	2020-05-08
ZA202304409B (en)	2024-08-28
KR20170063742A (ko)	2017-06-08
LT3194376T (lt)	2019-02-25
KR102209667B1 (ko)	2021-01-29
SG11201702194SA (en)	2017-04-27
MY176250A (en)	2020-07-24
TW201617335A (zh)	2016-05-16
BR112017005238A2 (pt)	2017-12-19
CN111909130B (zh)	2023-10-31
EP4257131A3 (en)	2024-01-10
EP3194376B1 (en)	2018-10-24
SMT201900018T1 (it)	2019-02-28
US10889567B2 (en)	2021-01-12
US11498913B2 (en)	2022-11-15
HRP20200666T1 (hr)	2020-07-24
SI3194376T1 (sl)	2019-03-29
US20180312487A1 (en)	2018-11-01
LT3447050T (lt)	2020-05-11
DK3194376T3 (en)	2019-01-21
US20240150319A1 (en)	2024-05-09
IL282363B (en)	2022-06-01
ES2953347T3 (es)	2023-11-10
IL292608B1 (en)	2024-06-01
EA201790657A1 (ru)	2017-08-31
PH12017500517A1 (en)	2017-08-07
WO2016044789A1 (en)	2016-03-24
RS60140B1 (sr)	2020-05-29
NZ758641A (en)	2023-12-22
RS58184B1 (sr)	2019-03-29
SA517381129B1 (ar)	2021-04-26
US9834539B2 (en)	2017-12-05
MY197533A (en)	2023-06-21
TWI686390B (zh)	2020-03-01
AU2021215141B2 (en)	2023-10-19
CA2961817C (en)	2024-03-12
AU2015317329A1 (en)	2017-04-27
CL2017000658A1 (es)	2017-12-22
EP3447050B1 (en)	2020-02-19
ES2790640T3 (es)	2020-10-28
CY1122865T1 (el)	2021-05-05
EP3733662A1 (en)	2020-11-04
JP6648115B2 (ja)	2020-02-14
ECSP17022933A (es)	2017-08-31
CN111909130A (zh)	2020-11-10
US20170174658A1 (en)	2017-06-22
CA2961817A1 (en)	2016-03-24
AU2019283765B2 (en)	2021-05-13
IL251163A0 (en)	2017-04-30
PH12017500517B1 (en)	2022-08-03
CO2017003241A2 (es)	2017-09-20
FI3733662T3 (fi)	2023-08-09
BR112017005238B1 (pt)	2023-01-17
ZA201702127B (en)	2019-06-26
AU2021215141A1 (en)	2021-09-02
US20190263778A1 (en)	2019-08-29
PT3447050T (pt)	2020-09-17
NZ730373A (en)	2019-11-29
CN107001328B (zh)	2020-06-05
IL282363A (en)	2021-06-30
PL3194376T3 (pl)	2019-05-31
US10414752B2 (en)	2019-09-17
IL292608B2 (en)	2024-10-01

Publication	Publication Date	Title
ME03776B (me)	2021-04-20	Derivati piridin-2(1h)-on hinolinona kao inhibitori mutirane izocitrat dehidrogenaze
MA40774A (fr)	2017-08-08	Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38
MA41140A (fr)	2017-10-17	Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg
MA47123A (fr)	2021-03-17	Dérivés de benzooxazole en tant qu'mmunomodulateurs
ME03574B (me)	2020-07-20	Heteroarilna jedinjenja koja su korisna kao inhibitori sumoaktivirajućeg enzima
EP3416964A4 (en)	2019-09-18	Carboxamide derivatives as RSK inhibitors
MA47125A (fr)	2021-04-28	Dérivés de pyrazole en tant qu'inhibiteurs de malt1
MA45189A (fr)	2019-04-10	Nouveaux dérivés hétérocycliques utiles en tant qu'inhibiteurs de shp2
MA46981A (fr)	2019-10-09	Dérivés de benzimidazole en tant qu'inhibiteurs de bromodomaine
MA40587A (fr)	2017-06-28	Composés d'aminopyrimidinyle en tant qu'inhibiteurs de jak
HUE056634T2 (hu)	2022-02-28	Rákellenes szerekként hasznos szubsztituált karbonukleozid-származékok
MA45244A (fr)	2019-04-17	Pyridines substituées utilisées en tant qu'inhibiteurs de dnmt1
MA40943A (fr)	2017-09-19	Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
MA40940A (fr)	2017-09-19	Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
MA54567A (fr)	2021-10-27	Pyridine et composés de pyridimine en tant qu'inhibiteurs de pi3k-gamma
IL252089A0 (en)	2017-07-31	2-amino-6-(difluoromethyl)- 5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors
FI20150068L (fi)	2016-09-11	Leuan liikkeen seuraaminen
MA46878A (fr)	2019-10-02	Composés de benzodiazolium en tant qu'inhibiteurs d'enac
HUE050974T2 (hu)	2021-01-28	Eljárás pirimidinszulfamid-származékok elõállítására
EP3457851A4 (en)	2020-02-26	DERIVATIVES OF SOBETIROM
DK3202766T3 (da)	2020-03-23	Isoxazolderivat som muteret isocitratdehydrogenase 1-inhibitor
IL250038A0 (en)	2017-03-30	4,5 - dehydroisoxazole derivatives used as nampt inhibitors
LT3445743T (lt)	2021-09-27	Aminorūgšties darinio provaistas
FR3023290B1 (fr)	2016-08-19	Derives de flavaglines
EP3102571A4 (en)	2016-12-14	EGFR-T790M KINASEINHIBITORS USEFUL SUBSTITUTED PYRIMIDINES